PSMD3 and chronic myelogenous leukemia, BCR-ABL1 positive: Our recent data in CML suggest that PSMD1 and PSMD3 act as oncogenes by stabilizing the nuclear factor-kappa B (NF-κB) transcription factor from degradation [31].